YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Gilead to acquire Tubulis

Posted online

Gilead Sciences Inc. has agreed to purchase German biotech firm Tubulis GmbH.

The deal is valued at up to $5 billion.

The agreement calls for $3.2 billion up front and more money if certain milestones are met.

Read more from Bloomberg.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Fall 2026 Architects & Engineers Project Report

This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.

Most Read
Update cookies preferences